Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) - World Forecasts to 2022
Format : 
Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Dec, 2016| No. of Pages : 75
Please make your selection :
Electronic Access - Single User License
US$ 1500.00
CD-ROM Mail Delivery
US$ 1700.00
Hard Copy Mail Delivery
US$ 1700.00
Electronic Access - Multi-User License
US$ 2500.00
List of Figures:
Figure 5-1: Global - Site-Specific Drug Delivery Market (Billion US$), 2016-2022
Figure 5-1: Global - Site-Specific Drug Delivery Market (Billion US$), 2016-2022
Figure 6-1: Global - Site-Specific Drug Delivery Market by Application (%), 2016
Figure 6-2: Global - Pulmonary Drug Delivery Market (Billion US$), 2016 & 2022
Figure 6-3: Global - Ocular Drug Delivery Market (Billion US$), 2016 & 2022
Figure 6-4: Global - Oncology Drug Delivery Market (Billion US$), 2016 & 2022
Figure 6-5: Global - Others Drug Delivery Market (Billion US$), 2016 & 2022
Figure 7-1: Global - Site-Specific Drug Delivery Market by Geography (%), 2016
Figure 7-2: North America - Site-Specific Drug Delivery Market (Billion US$), 2016 & 2022
Figure 7-3: Europe - Site-Specific Drug Delivery Market (Billion US$), 2016 & 2022
Figure 7-4: Asia Pacific - Site-Specific Drug Delivery Market (Billion US$), 2016 & 2022
Figure 10-1: Celgene Corporation - Net Sales Breakup by Products (%), 2015
List of Tables:
Table 12-1: Celgene Corporation - Product Portfolio
Table 12-2: Celgene Corporation - Product Pipeline
Table 12-3: Celgene Corporation - Key Financials (Million US$), 2013-2015
Table 12-4: Arrowhead Pharmaceuticals, Inc. - Product Pipeline
Table 12-5: Arrowhead Pharmaceuticals, Inc. - Key Financials (Million US$), 2013-2015
Table 12-6: BioDelivery Sciences International, Inc. - Product Portfolio
Table 12-7: BioDelivery Sciences International, Inc. - Product Pipeline
Table 12-8: BioDelivery Sciences International, Inc. - Key Financials (Million US$), 2012-2014
Table 12-9: Endocyte, Inc. - Technology Portfolio
Table 12-10: Endocyte, Inc. - Product Pipeline
Table 12-11: Endocyte, Inc. - Key Financials (Million US$), 2013-2015
Table 12-12: Intezyne, Inc. - Product Pipeline
Table 12-13: PharmaIN - Technology Portfolio
Table 12-14: PharmaIN - Product Pipeline
Table 12-15: Kurve Technology, Inc. - Product & Technology Portfolio
Table 12-16: Mirus Bio LLC. - Product & Service Portfolio
Table 12-17: Savara Inc. - Product Portfolio
Table 12-18: Savara Inc. - Product Pipeline
Table 12-19: Delpor, Inc. - Product & Technology Portfolio
Table 12-20: Delpor, Inc. - Product Pipeline
Not able to find data you are looking for? Ask our Research Analyst.
media citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2018, RNCOS, 2002-2018
About Us
Terms & Policy
Contact